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Abstract
Background: In the year 2000, the South Korean government introduced a program for separation of drug
prescribing and dispensing. The goals of the program are to reduce misuse of drugs and to contain drug
expenditures. The government also designated exception regions for the program to reduce the inconvenience for
people who reside in areas with a shortage of health care resources. However, according to government reports,
many adverse events related to drug misuse occurred in these exception regions after the program reforms were
introduced. Therefore, it is worth investigating the factors that relate to drug consumption so that misuse in
exception regions can be reduced.
Methods: Data from medical institutions, detailed drug supply data, and community health survey data were
included in the analysis. Multilevel linear regression analysis using mixed models that included pharmacy—and
regional-level variables were used to examine the associations regarding the percentages of drug types consumed
(i.e., antipyretic, analgesic, anti-inflammatory drugs, psychotropic drugs, adrenal cortical hormones, and antibiotics).
Results: The data used in this analysis were from a total of 16,455 pharmacies. There were 1.9 % pharmacies
from program exception regions and 98.1 % pharmacies from program application regions. Compared with the
pharmacies in the program application regions, the exception region pharmacies had higher values for percent
consumption of the antipyretic, analgesic, anti-inflammatory drugs category, and of the adrenal cortical hormones
category (antipyretic, analgesic, anti-inflammatory drugs = β: 3.19, Standard Error (SE): 0.82, t: 3.88, p-value < 0.05;
adrenal cortical hormones = β: 0.72, SE: 0.07, t: 9.92, p-value < 0.05).
Conclusion: Our results suggested that pharmacies in exception regions supplied more antipyretic, analgesic,
anti-inflammatory drugs, and more adrenal cortical hormones compared with the pharmacies where separation
of drug prescribing and dispensing had been implemented. Health care professionals and health policy makers
should consider management of health care expenditure by the category of drugs consumed, especially in
program exception regions.
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Background
South Korea has experienced gradual socio-economic
development since the 1980s. This development has
resulted in increased health care accessibility and demand,
and the consumption of medical care by South Koreans
has gradually increased. Individuals have easier access
to medical resources compared with the past, and the
consumption of general pharmaceutical products has
increased [1]. The overall health status of the popula-
tion has improved, but new problems (e.g., increasing
medical costs) have developed. Solutions to these
problems are needed [2].
In the year 2000, the Korean government introduced
a program reform that separated the prescribing and
dispensing of pharmaceutical drugs. The objectives of
the reform were to reduce misuse of drugs, and to contain
drug expenditures. Before the program was introduced,
individual physicians and pharmacists could both
prescribe and dispense drugs, which was a system that
resulted in an inefficient treatment for the patient. How-
ever, application of the program reform to all of South
Korea was difficult because of the presence of regions with
shortages of health care resources [3, 4]. To reduce the
inconvenience of populations residing in these areas, the
South Korean government designated these regions as
exceptions to the separation of prescribing and dispensing
rule. It was expected that reforming the program would
result in a more efficient management of consumption
and reduced pharmaceutical expenditures [5].
Contrary to government expectations, pharmaceutical
expenditures were not well-controlled after the program
reform was introduced. Organization for Economic Co-
operation and Development (OECD) health data expend-
iture trend analyses results indicate that compared with
other OECD countries, expenditure for pharmaceuticals
in South Korea has gradually increased (Y2000 = average
for OECD countries: 1.3 % of Gross Domestic Product
(GDP), South Korea: 1.0 % of GDP; Y2005 = average for
OECD countries: 1.4 % of GDP, South Korea: 1.3 % of
GDP; Y2010 = average for OECD countries: 1.4 % of
GDP, South Korea: 1.6 % of GDP) [6].
To investigate the factors associated with this problem,
many health care professional have examined factors
associated with the separation of drug prescribing and dis-
pensing [7–9]. Few studies examining the effects of the ex-
ception regions have been published [10]. The South
Korean government reported that many adverse events re-
lated to drug misuse have occurred in the exception re-
gions since the program reforms were introduced [11, 12].
Under the reformed pharmaceutical affairs act, pharmacist
with pharmacy in exception regions for separation of drug
prescribing and dispensing could prescribe medication to
patients without a doctor’s prescription. Therefore, the
monitoring for providing health care was not well
managed compared to those in the application region. For
that reason, it might easily cause many adverse events
related to misuse. Nevertheless, there were no evidence-
based studies about the factors associated with pharma-
ceutical expenditures to reconsider the program for
separation of drug prescribing and dispensing. Hence to
solve that problem, the aim of our study was to analyze
the factors associated with drug consumption in the
exception regions compared with the application regions.
Methods
Sampled data
Three types of data were combined for analysis. We first
sampled the study pharmacies included in the medical
institution data of the Health Insurance Review & As-
sessment Service. Next, to analyze drug consumption
details and to examine the regional characteristics of
each pharmacy, we merged drug supply details from
the Korea Pharmaceutical Information Service Center
and the community health survey of the Korea Centers
for Diseases Control & Prevention with sampling data
from medical institutions. These data were collected
between 2011 and 2013 and included 26,063 pharma-
cies. We excluded data from pharmacies with more
than one pharmacist, pharmacies that relocated dur-
ing the study period, and pharmacies that did not
supply financial details of the supplied drugs, from
the analysis. Finally, the data used in this study con-
sisted of 16,455 pharmacies in 247 regions (Fig. 1).
Variables
The outcome variable was percent drug consumption
of drugs including antipyretics, analgesics, anti-
inflammatories, psychotropic drugs, adrenal cortical hor-
mones, and antibiotics, of the total drug consumption for
each pharmacy. This variable was defined as the ratio of
the sum of pharmacy costs for specific drug purchase to
the total pharmacy costs for drug purchase in each phar-
macy. The percentages were calculated as:
Percentage of drug consumption
¼ ðsum of pharmacy costs f or specific drug =
total pharmacy costs f or drug purchaseÞ x 100
The primary variable of interest was exception from/
application to the separation of drug prescribing and
dispensing program. Whether a pharmacy was in an
exception region was defined using the criteria established
by the program policy decision makers:
1) Island region or rural region without a medical
institution
2) Region with a pharmacy, designated as an exception
region by decision makers
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3) Region where distance between medical institution
and pharmacy was >1 km
4) Region within a military installation security zone or
within a limited development district
We adjusted for pharmacy-level and regional-level
variables when we analyzed the relationships between
program designation (i.e., exception region or application
region) and drug consumption rate. Pharmacy-level vari-
ables encompassed both pharmacist and pharmacy charac-
teristics: Sex of pharmacist, Age of Pharmacist, period of
time pharmacy had been in business, whether separation
of drug prescribing and dispensing occurred, time period
that the program applied, and total drug purchase amount.
Age-groups were categorized as <45 years, 46–55 years,
56–65 years, and ≥66 years. The period of time the phar-
macy had been in business was defined as the time since a
pharmacy first began operation. This variable was catego-
rized as <12 months, 13–24 months, and ≥25 months. The
time period designated as an exception region was defined
as the period during which the program exception criteria
was applied. The total pharmacy costs for drug purchase
were calculated as the total amount spent to supply the
drugs in each pharmacy during the study period. The char-
acteristics of the regions with the pharmacies were as fol-
lows: name of region, total number of clinics in the region,
total number of pharmacies in the region, mean individual
income in the region, and the proportion of national basic
livelihood security beneficiaries in the region. Total num-
ber of clinics/pharmacies in the region was categorized
by each average value. In addition, the proportion of
national basic livelihood security beneficiaries in a re-
gion was calculated as the number of national basic
livelihood security beneficiaries divided by the total
population size.
Statistical analysis
We first analyzed the general characteristics of each
group by examining the distributions of each variable.
We performed χ2 tests and Mann–Whitney U tests to
examine differences in each variable by program desig-
nation. Next, we performed Mann–Whitney U tests and
Kruskal-Wallis tests to compare the average values and
standard deviations for the percentage of specific drug
consumption with the independent variables, because
dependent variables in this study were continuous and
did not have a normal distribution.
Third, multilevel linear regression analysis using mixed
models that included pharmacy—and regional-level vari-
ables were utilized to examine the associations between
program designation (i.e., exception region or application
region) and percentages of drug consumption (antipyretic,
analgesic, anti-inflammatory drugs, and psychotropic
drugs, adrenal cortical hormones, and antibiotics) in
hierarchical data which was consisted of pharmacy and
regional levels [13, 14].
In using such methodology, we compared model
specification by each model (model 1 = empty model,
model 2 = only adjusted pharmacist and pharmacy level,
model 3 = only adjusted regional level, and model 4 = fully
adjusted). We also compared intra-class correlation coeffi-
cient (ICC) to examine the reliability of each level variable
for the outcome variable. The ICC was defined as the ratio
of the between cluster variance to the total variance. It
was interpreted through correlation among observations
within the same cluster.
Finally, we performed sub-group analysis for multilevel
linear regression analysis in the exception regions
with respect to pharmacist (age and sex) and pharmacy
(region and time since open for business) characteristics.
All analyses were performed using SAS software (ver. 9.2,
Cary, North Carolina, USA). A P-value <0.05 was consid-
ered to indicate a statistically significant result.
Results
A total of 16,455 pharmacies were included in the analysis.
There were 1.9 % pharmacies in the exception regions and
98.1 % pharmacies in the program application regions.
Table 1 presents the results of the univariate analyses
between the independent variables and the program desig-
nation. Based on the results of the Chi-square test for cat-
egorical variables, the exception regions had more male
Fig. 1 Sampling method for data used in this study
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pharmacists than the application regions (X2 = 62.6,
degrees of freedom; df = 1, P < .0001). Exception re-
gions also had higher percentages of elderly pharma-
cists (X2 = 168.1, df = 3, P < .0001). Compared with the
program application pharmacies, a higher percentage
of the program exception pharmacies were located in
non-metropolitan areas (X2 = 254.9, df = 1, P < .0001).
There were higher numbers of clinics/pharmacies in the
program application regions. In the results of Mann–
Whitney U test for comparing the averages and standard
deviations in continuous variables, it can be seen that the
average values of pharmacy total drug purchase amount
Table 1 General characteristics of pharmacists and pharmacies
Variables Separation of drug prescribing and dispensing (N=16,455) Test statistics (df) P-Value
Exception Application
N/Mean %/SD N/Mean %/SD
Pharmacy characteristics
Sex of pharmacist
Male 224 72.5 8,036 49.8 X2(1)=62.6
Female 85 27.5 8,110 50.2
Age of pharmacist (years)
≤45 27 8.7 4,890 30.3 X2(3)=168.1 <.0001a
46–55 51 16.5 4,367 27.1
56–65 74 24 3,268 20.2
≥66 157 50.8 3,621 22.4
Length of Operation
≤12 months 48 15.5 2,329 14.4 X2(2)=5.4 0.067a
13–24 months 49 15.9 1,914 11.9
≥25 months 212 68.6 11,903 73.7
Period of exclusion for reformed program
≤18 months 95 30.7 16,146 100 X2(1)=11329.4 <.0001a
≥19 months 214 69.3 0 0
Total pharmacy cost for drug purchase (10 million KRW) 18.0 ±19.1 75.0 ±75.2 Z=−18.7 <.0001b
Regional Characteristics
Region
Metropolitan (N=74) 14 4.5 8,134 50.4 X2(1)=254.9 <.0001a
Non-metropolitan (N=173) 295 95.5 8,012 49.6
Total number of clinics in regions with pharmacies
≤60 (N=212) 304 98.4 11,961 74.1 X2(1)=94.3
≥61 (N=35) 5 1.6 4,185 25.9
Total number of pharmacies in regions with pharmacies
≤45 (N=176) 273 88.4 10,606 65.7 X2(1)=69.5
≥46 (N=71) 36 11.7 5,540 34.3
Average per capita income in regions with pharmacies
≤38 million KRW (N=175) 232 75.1 8,442 52.3 X2(1)=63.2
≥39 million KRW (N=72) 77 24.9 7,704 47.7
Proportion of national basic livelihood security
beneficiaries in regions with pharmacies
3.2 ±1.6 2.9 ±1.5 Z=3.7 0.0002b
Total 309 1.9 16,146 98.1
Note. Significant level P < 0.05. If these values were lower than 0.05, it indicated that the distribution or mean/standard deviation of each independent variable
were differenced by separation of drug prescribing and dispensing. KRW Republic of Korea Won, df degrees of freedom
aP for Chi-square test, Chi-square tests were used to examine the differences in distribution of each categorical variable by separation of drug prescribing
and dispensing
bp for Mann–Whitney U test, Mann–Whitney U tests were used to examine differences in mean/standard deviation of each continuous variable by separation of
drug prescribing and dispensing
Yuk et al. Substance Abuse Treatment, Prevention, and Policy  (2015) 10:36 Page 4 of 19
was lower in exception region pharmacies (Z = −18.7,
P < .0001). The average values for individual income
was also higher in program application regions (Z = 3.7,
P = 0.0002) (Table 1).
Table 2 presents the results for Mann–Whitney U test
and Kruskal-Wallis test to compare average values and
standard deviation regarding the percentages of specific
drugs consumed by each independent variable. Based on
the results of Mann–Whitney U test, the average per-
centages of antipyretic, analgesic, anti-inflammatory
drugs, and adrenal cortical hormones were higher in the
exception regions compared to the application regions
(antipyretic, analgesic, anti-inflammatory drugs = Z: 18.5,
P < .0001; adrenal cortical hormones = Z: 14.0, P < .0001).
The average percentages of those 2 types of drugs con-
sumed were higher for pharmacies that had been operat-
ing in an exception region for a longer period of time
(antipyretic, analgesic, anti-inflammatory drugs = Z: 16.8,
P < .0001; adrenal cortical hormones = Z: 12.2, P < .0001).
In the results of the Kruskal-Wallis test, the average of
drugs consumed for psychotropic drugs, adrenal cortical
hormones, and antibiotics were higher in pharmacies
which were in operation for a shorter time (psychotropic
drugs = X2: 8.2, df: 2, P = 0.0109; adrenal cortical hor-
mones = X2: 18.4, df: 2, P < .0001; antibiotics = X2: 173.7,
df: 2, P < .0001) (Table 2).
Tables 3, 4, 5 and 6 presents the results of the multi-
level regression analysis using mixed model for adjusting
pharmacy—and regional-level analyses. In the results for
antipyretic, analgesic, anti-inflammatory drugs, pharma-
cies with male pharmacists and elderly pharmacists were
more likely to dispense antipyretic, analgesic, anti-
inflammatory drugs. Pharmacies that had been in oper-
ation for a longer time period were inversely associated
with the consumption of antipyretic, analgesic, anti-
inflammatory drugs. The total pharmacy costs for drug
purchase, which is an indirect indicator for the size of
each pharmacy, were inversely related to the percentages
of antipyretic, analgesic, anti-inflammatory drugs con-
sumed. The pharmacies in exception regions had higher
values for percentages of antipyretic, analgesic, anti-
inflammatory drugs dispensed compared to pharmacies
in the program application regions (β: 3.19, Standard
Error (SE): 0.82, t: 3.88, df: 93, p-value < 0.05). By the re-
sults of the regional-level variables, pharmacies which
were located in metropolitan regions had inverse associ-
ations with less drug consumption. The region with
higher individual income also had such relationships. A
higher proportion of national basic livelihood security
beneficiaries had higher consumption percentages of
drugs in the antipyretic, analgesic, anti-inflammatory
drug category (Table 3). In the results regarding psycho-
tropic drugs, pharmacies with younger pharmacists or
with shorter lengths of operation were more likely to
dispense psychotropic drugs. However, there were no
significant relationships with the separation of drug pre-
scribing and dispensing (β: −0.18, SE: 0.25, t: −0.71, df:
93, p-value: 0.4813). The total pharmacy costs for drug
purchase correlated to the percentages of psychotropic
drug (β: 0.01, SE: 0.0003, t: 16.80, df: 16,000, p-value <
0.0001) (Table 4). On the other hand, the results of ad-
renal cortical hormones indicated that pharmacies with
shorter lengths of operation correlate with drug consump-
tion. The pharmacies in exception regions had higher
values for adrenal cortical hormones drugs dispensed
compared to pharmacies in the program application re-
gions (β: 0.72, SE: 0.07, t: 9.92, df: 93, p-value < 0.0001).
The total pharmacy costs for drug purchase were inversely
related to the percentages of drugs consumed in the ad-
renal cortical hormone category. Based on the results of
regional-level variables, pharmacies which were located in
metropolitan regions had inverse associations with
less drug consumption (β: −0.04, SE: 0.02, t: −2.07, df: 241,
p-value = 0.0395) (Table 5). The results for antibiotics had
no interesting findings compared with other categories of
drugs. Pharmacies with younger pharmacists were more
likely to dispense antibiotic drugs. Also, the total phar-
macy costs for drug purchase had inverse associations
with drug consumption (Table 6).
Using the methodologies related to multilevel linear
regression analysis, we investigated model specification
by comparing the results in each model (model 1 to 4).
Based on the results, it can be seen that both pharma-
cy—and regional-level variables had statistically signifi-
cant associated to outcome variables, but that there
were no significant relationship regarding antibiotics.
These results showed that regional characteristics do not
have significant associations in the consumption of anti-
biotics (Table 6). We compared the ICC to examine the
reliability of each level variable for the outcome variable.
The ICC in the fully adjusted model were estimated as
follows = Antipyretic; Analgesic; Anti-inflammatory drugs:
0.0032, Psychotropic drugs: 0.0061, Adrenal cortical
hormones: 0.0149, and Antibiotics: 0.0001. These values
indicated that the regional-level variables explained the
0.3, 0.6, 1.5, and 0.01 % of the total variability in outcomes,
respectively (Tables 3, 4, 5 and 6).
We also performed sub-group analyses for multilevel
regression analysis in exception regions by the sex of
pharmacist, age of pharmacist, regional characteristics of
the pharmacy, and the length of time the pharmacy had
been in operation. The results for the sub-group analysis
by sex indicated that for both sex groups, exception re-
gions had higher percentages of drug consumption of
drugs in the antipyretic, analgesic, anti-inflammatory
category, and for adrenal cortical hormones category,
compared to the application regions. The results of the
sub-group analysis performed by age was generally
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Table 2 Percentages of drug consumption categorized by pharmacist and pharmacy variables, by four drug categories
Variables Antipyretic; Analgesic; Psychotropic drugs Adrenal cortical hormones Antibiotics
Anti-inflammatory drugs
Mean SD Test statistics (df) P-Value Mean SD Test statistics (df) P-Value Mean SD Test statistics (df) P-Value Mean SD Test statistics (df) P-Value
Pharmacy characteristics
Sex of pharmacist
Male 9.86 9.46 Z = −11.6574 <.0001† 0.82 2.35 Z = 4.6 <.0001† 0.29 0.71 Z = −3.3 0.0021† 6.77 30.87 Z = 7.9 <.0001†
Female 9.03 6.46 0.91 2.47 0.28 0.68 7.24 8.71
Age of pharmacist (years)
≤45 9.20 11.17 X2(3) = 382.8 <.0001a 0.95 2.63 X2(3) = 207.2 <.0001a 0.32 0.73 X2(3) = 85.1 <.0001a 8.90 32.82 X2(3) = 378.3 <.0001a
46–55 8.72 5.99 0.98 2.35 0.26 0.55 7.00 7.96
56–65 9.30 5.88 0.89 2.68 0.26 0.60 6.01 9.07
≥66 10.75 7.04 0.60 1.83 0.30 0.87 5.44 26.32
Length of operation
≤12 months 9.94 15.77 X2(2) = 1.4 0.3231a 0.92 2.67 X2(2) = 8.2 0.0109a 0.35 0.96 X2(2) = 18.4 <.0001a 10.45 56.56 X2(2) = 173.7 <.0001a
13–24 months 9.64 6.25 0.86 2.02 0.33 0.78 7.99 8.58
≤25 months 9.32 5.86 0.86 2.41 0.27 0.62 6.17 7.66
Separation of drug prescribing and dispensing
Exception 15.21 6.31 Z = 18.5 <.0001† 0.39 1.08 Z = −15.2 <.0001† 1.09 1.55 Z = 14.0 <.0001† 6.01 8.81 Z = 2.3 0.0232†
Application 9.34 8.11 0.88 2.42 0.27 0.66 7.03 22.91
Period of exclusion for reformed program
≤18 months 9.36 8.11 Z = 16.8 <.0001† 0.87 2.42 Z = −14.1 <.0001† 0.28 0.67 Z = 12.2 <.0001† 7.02 22.87 Z = 2.8 0.0057†
≥19 months 15.69 5.63 0.34 1.12 1.10 1.57 5.76 3.61
Regional characteristics
Region
Metropolitan 9.12 6.23 Z = −10.5 <.0001† 0.86 2.60 Z = −8.1 <.0001† 0.26 0.63 Z = −11.3 <.0001† 7.00 19.34 Z = −2.0 0.0404†
Non-metropolitan 9.77 9.61 0.88 2.20 0.32 0.76 7.02 25.61
Total number of clinics in regions with pharmacies
≤60 9.53 6.19 Z = −7.5 <.0001† 0.86 2.44 Z = −3.1 0.0020† 0.29 0.71 Z = −6.5 <.0001† 6.99 16.42 Z = −3.7 0.†
≥61 9.21 12.1 0.89 2.29 0.27 0.66 7.05 35.20
Total number of pharmacies in region with pharmacies
≤45 9.45 6.20 Z = −2.2 0.0296† 0.88 2.57 Z = 0.2 0.8213† 0.30 0.69 Z = −9.2 <.0001† 7.30 16.90 Z = −13.3 <.0001†
≥46 9.45 10.93 0.85 2.06 0.26 0.71 6.44 31.08
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Table 2 Percentages of drug consumption categorized by pharmacist and pharmacy variables, by four drug categories (Continued)
Average per capita income in regions with pharmacies
≤38 million KRW 9.77 9.48 Z = −9.2 <.0001† 0.87 2.22 Z = −9.6 <.0001† 0.29 0.69 Z = −4.5 <.0001† 6.55 25.65 Z = 11.3 <.0001†
≥39 million KRW 9.09 6.23 0.87 2.59 0.28 0.71 7.52 18.92
Total 9.40 8.10 0.90 2.40 0.30 0.70 7.00 22.70
Note. Significant level P < 0.05. If these values were lower than 0.05, it indicated that the mean/standard deviation of drug consumption were differenced by each independent variable. KRW Republic of Korea Won, df
degrees of freedom
†p for Mann–Whitney U test, Mann–Whitney U tests were used to examine differences in mean/standard deviation of drug consumption by each categorical variable as these did not have normal distribution and
below than 3 groups
ap for Kruskal-Wallis test, Kruskal-Wallis tests were used to examine differences in mean/standard deviation of drug consumption by each categorical variable as these did not have normal distribution and above than
3 groups
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Table 3 Results for multi-level analyses of the associations with percentages of drug consumption in Antipyretic; Analgesic; Anti-inflammatory drugs
Variables Antipyretic; Analgesic; Anti-inflammatory drugs
Model 1 Model 2 Model 3 Model 4
β SE t df P-Value β SE t df P-Value β SE t df P-Value β SE t df P-Value
Intercept 9.51 0.08 120.05 246 <.0001 12.68 0.99 12.80 246 <.0001 9.23 0.27 34.53 241 <.0001 12.26 1.02 12.03 241 <.0001
Pharmacy characteristics
Sex of pharmacist
Male 0.64 0.13 5.00 243 <.0001 0.52 0.13 4.03 243 <.0001
Female Ref - - Ref - - Ref - - Ref - -
Age of pharmacist (years)
≤45 −0.65 0.18 −3.62 722 0.0003 −0.66 0.18 −3.65 722 0.0003
46–55 −0.82 0.18 −4.48 722 <.0001 −0.82 0.18 −4.45 722 <.0001
56–65 −0.62 0.19 −3.26 722 0.0012 −0.59 0.19 −3.07 722 0.0022
≥66 Ref - - Ref - - Ref - - Ref - -
Length of operation
≤12 months −1.06 0.20 −5.35 454 <.0001 −1.08 0.20 −5.47 454 <.0001
13–24 months −0.80 0.20 −3.97 454 <.0001 −0.81 0.20 −4.01 454 <.0001
≥25 months Ref - - Ref - - Ref - - Ref - -
Separation of drug prescribing
and dispensing
Exception 3.41 0.82 4.14 93 <.0001 3.19 0.82 3.88 93 0.0002
Application Ref - - Ref - - Ref - - Ref - -
Period of exclusion for
reformed program
≤18 months −1.05 0.98 −1.07 88 0.2860 −0.93 0.98 −0.95 88 0.3455
≥19 months Ref - - Ref - - Ref - - Ref - -
Total drug purchase
(10 million KRW)
−0.02 0.00 −25.37 16,000 <.0001 −0.02 0.00 −25.93 16,000 <.0001
Regional characteristics
Region
Metropolitan −0.53 0.16 −3.22 241 0.0015 −0.56 0.16 −3.57 241 0.0004
Non-metropolitan Ref - - Ref - - Ref - - Ref - -
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Table 3 Results for multi-level analyses of the associations with percentages of drug consumption in Antipyretic; Analgesic; Anti-inflammatory drugs (Continued)
Total number of clinics in
regions with pharmacies
≤60 0.21 0.21 1.03 241 0.3027 0.12 0.20 0.61 241 0.5431
≥61 Ref - - Ref - - Ref - - Ref - -
Total number of pharmacy in
regions with pharmacies
≤45 −0.18 0.19 −0.92 241 0.3597 −0.17 0.18 −0.92 241 0.3574
≥46 Ref - - Ref - - Ref - - Ref - -
Average of individual income
in regions with pharmacies
≤38 million KRW 0.47 0.17 2.73 241 0.0067 0.43 0.16 2.63 241 0.0091
≥39 million KRW Ref - - Ref - - Ref - - Ref - -
Proportion of national basic
livelihood security beneficiaries
in regions with pharmacies
0.07 0.06 1.21 241 0.2271 0.14 0.05 2.72 241 0.0070
Random parta Variance SE Z P-Value Variance SE Z P-Value Variance SE Z P-Value Variance SD Z P-Value
Variance of the intercept at
the regional level
0.39 0.12 3.26 0.0005 0.35 0.11 3.26 0.0006 0.27 0.10 2.55 0.0054 0.20 0.09 2.29 0.0111
Variance of the intercept at
the pharmacy level
65.48 0.73 90.21 <.0001 61.92 0.69 90.23 <.0001 65.44 0.73 90.24 <.0001 61.85 0.69 90.28 <.0001
ICC 0.0059 0.0055 0.0040 0.0032
Note. The results of multilevel linear regression analysis using mixed model to examine associations between program designation (i.e., exception region or application region) and percentages of drug consumption
(antipyretic, analgesic, anti-inflammatory drugs, and psychotropic drugs, adrenal cortical hormones, and antibiotics) in hierarchical data which was consisted of pharmacy and regional levels. Significant level P < 0.05.
If these values were lower than 0.05, it indicated that there were statistically significant associations between independent variable and drug consumption
Model 1 = empty model, Model 2 = only adjusted for pharmacy-level variables, Model 3 = only adjusted regional-level variables, Model 4 = fully adjusted
KRW Republic of Korea Won, ICC Intra-class Correlation Coefficient, the results were rounded to the second digit after the decimal point, df degrees of freedom
aIf p-value were lower than 0.05, it indicated that each level variable had statistically significant association with the outcome variables. The ICC was defined that the ratio of the between cluster variance to the total
variance. It was interpreted as the correlation among observations within the same cluster
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Table 4 Results for multi-level analyses of the associations with percentages of drug consumption in Psychotropic drugs
Variables Psychotropic drugs
Model 1 Model 2 Model 3 Model 4
β SE t df P-Value β SE t df P-Value β SE t df P-Value β SE t df P-Value
Intercept 0.86 0.02 36.54 246 <.0001 0.38 0.30 1.27 246 0.2040 0.89 0.09 10.24 241 <.0001 0.43 0.31 1.40 241 0.1635
Pharmacists and pharmacy
characteristics
Sex of pharmacist
Male −0.07 0.04 −1.73 243 0.0842 −0.07 0.04 −1.65 243 0.0995
Female Ref - - Ref - - Ref - - Ref - -
Age of pharmacist (years)
≤45 0.15 0.05 2.74 722 0.0064 0.15 0.05 2.70 722 0.0070
46–55 0.16 0.06 2.94 722 0.0034 0.16 0.06 2.88 722 0.0040
56–65 0.14 0.06 2.46 722 0.0142 0.14 0.06 2.42 722 0.0157
≥66 Ref - - Ref - - Ref - - Ref - -
Length of operation
≤12 months 0.41 0.06 6.88 454 <.0001 0.41 0.06 6.87 454 <.0001
13-24 months 0.22 0.06 3.63 454 0.0003 0.22 0.06 3.62 454 0.0003
≥25 months Ref - - Ref - - Ref - - Ref - -
Separation of drug prescribing
and dispensing
Exception −0.18 0.25 −0.72 93 0.4741 −0.18 0.25 −0.71 93 0.4813
Application Ref - - Ref - - Ref - - Ref - -
Period of exclusion for
reformed program
≤18 months −0.03 0.30 −0.11 88 0.9134 −0.03 0.30 −0.12 88 0.9075
≥19 months Ref - - Ref - - Ref - - Ref - -
Total drug purchase
(10 million KRW)
0.00 0.00 16.85 16,000 <.0001 0.01 0.00 16.80 16,000 <.0001
Regional characteristics
Region
Metropolitan −0.05 0.05 −0.90 241 0.3677 −0.02 0.05 −0.34 241 0.7348
Non-metropolitan Ref - - Ref - - Ref - - Ref - -
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Table 4 Results for multi-level analyses of the associations with percentages of drug consumption in Psychotropic drugs (Continued)
Total number of clinics in
regions with pharmacies
≤60 −0.08 0.07 −1.18 241 0.2392 −0.07 0.07 −1.10 241 0.2733
≥61 Ref - - Ref - - Ref - - Ref - -
Total number of pharmacy in
regions with pharmacies
≤45 0.04 0.06 0.63 241 0.5302 0.03 0.06 0.50 241 0.6175
≥46 Ref - - Ref - - Ref - - Ref - -
Average of individual income
in regions with pharmacies
≤38 million KRW −0.01 0.06 −0.14 241 0.8855 −0.01 0.05 −0.16 241 0.8746
≥39 million KRW Ref - - Ref - - Ref - - Ref - -
Proportion of national basic
livelihood security beneficiaries
in regions with pharmacies
0.01 0.02 0.75 241 0.4500 0.00 0.02 −0.06 241 0.9499
Random parta Variance SE Z P-Value Variance SE Z P-Value Variance SE Z P-Value Variance SD Z P-Value
Variance of the intercept at
the regional level
0.04 0.01 3.40 0.0003 0.03 0.01 3.24 0.0006 0.04 0.01 3.45 0.0003 0.03 0.01 3.29 0.0005
Variance of the intercept at
the pharmacy level
5.76 0.06 90.23 <.0001 5.64 0.06 90.20 <.0001 5.76 0.06 90.22 <.0001 5.64 0.06 90.19 <.0001
ICC 0.0061 0.0057 0.0064 0.0061
Note. The results of multilevel linear regression analysis using mixed model to examine associations between program designation (i.e., exception region or application region) and percentages of drug consumption
(antipyretic, analgesic, anti-inflammatory drugs, and psychotropic drugs, adrenal cortical hormones, and antibiotics) in hierarchical data which was consisted of pharmacy and regional levels. Significant level P < 0.05.
If these values were lower than 0.05, it indicated that there were statistically significant associations between independent variable and drug consumption
Model 1 empty model, Model 2 only adjusted for pharmacy-level variables, Model 3 only adjusted regional-level variables, Model 4 fully adjusted
KRW Republic of Korea Won, ICC Intra-class Correlation Coefficient, the results were rounded to the second digit after the decimal point, df degrees of freedom
aIf p-value were lower than 0.05, it indicated that each level variable had statistically significant association with the outcome variables. The ICC was defined that the ratio of the between cluster variance to the total
variance. It was interpreted as the correlation among observations within the same cluster
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Table 5 Results for multi-level analyses of the associations with percentages of drug consumption in Adrenal cortical hormones
Variables Adrenal cortical hormones
Model 1 Model 2 Model 3 Model 4
β SE t df P-Value β SE t df P-Value β SE t df P-Value β SE t df P-Value
Intercept 0.30 0.01 32.20 246 <.0001 0.38 0.09 4.38 246 <.0001 0.31 0.03 9.15 241 <.0001 0.41 0.09 4.48 241 <.0001
Pharmacists and pharmacy
characteristics
Sex of pharmacist
Male 0.00 0.01 −0.02 243 0.9876 0.00 0.01 −0.19 243 0.8498
Female Ref - - Ref - - Ref - - Ref - -
Age of pharmacist (years)
≤45 0.04 0.02 2.25 722 0.0251 0.03 0.02 2.10 722 0.0361
46–55 0.00 0.02 −0.21 722 0.8342 −0.01 0.02 −0.37 722 0.7139
56–65 −0.02 0.02 −0.93 722 0.3528 −0.02 0.02 −1.01 722 0.3152
≥66 Ref - - Ref - - Ref - - Ref - -
Length of operation
≤12 months 0.05 0.02 2.78 454 0.0057 0.05 0.02 2.74 454 0.0064
13–24 months 0.03 0.02 1.92 454 0.0555 0.03 0.02 1.89 454 0.0595
≥25 months Ref - - Ref - - Ref - - Ref - -
Separation of drug prescribing
and dispensing
Exception 0.72 0.07 10.05 93 <.0001 0.72 0.07 9.92 93 <.0001
Application Ref - - Ref - - Ref - - Ref - -
Period of exclusion for
reformed program
≤18 months −0.10 0.09 −1.16 88 0.2484 −0.10 0.09 −1.17 88 0.2442
≥19 months Ref - - Ref - - Ref - - Ref - -
Total drug purchase
(10 million KRW)
0.00 0.00 −3.68 16,000 0.0002 0.00 0.00 −3.68 16,000 0.0002
Regional characteristics
Region
Metropolitan −0.06 0.02 −3.00 241 0.0030 −0.04 0.02 −2.07 241 0.0395
Non-metropolitan Ref - - Ref - - Ref - - Ref - -
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Table 5 Results for multi-level analyses of the associations with percentages of drug consumption in Adrenal cortical hormones (Continued)
Total number of clinics in
regions with pharmacies
≤60 0.01 0.03 0.24 241 0.8108 −0.01 0.02 −0.27 241 0.7887
≥61 Ref - - Ref - - Ref - - Ref - -
Total number of pharmacy in
regions with pharmacies
≤45 0.02 0.02 0.98 241 0.3303 0.01 0.02 0.50 241 0.6149
≥46 Ref - - Ref - - Ref - - Ref - -
Average of individual income
in regions with pharmacies
≤38 million KRW 0.01 0.02 0.37 241 0.7088 −0.01 0.02 −0.31 241 0.7555
≥39 million KRW Ref - - Ref - - Ref - - Ref - -
Proportion of national basic
livelihood security beneficiaries
in regions with pharmacies
0.00 0.01 −0.72 241 0.4740 0.00 0.01 −0.52 241 0.6035
Random parta Variance SE Z P-Value Variance SE Z P-Value Variance SE Z P-Value Variance SD Z P-Value
Variance of the intercept at
the regional level
0.01 0.00 4.76 <.0001 0.01 0.00 4.13 <.0001 0.01 0.00 4.42 <.0001 0.01 0.00 3.99 <.0001
Variance of the intercept at
the pharmacy level
0.48 0.01 89.74 <.0001 0.47 0.01 89.77 <.0001 0.48 0.01 89.72 <.0001 0.47 0.01 89.76 <.0001
ICC 0.0223 0.0151 0.0199 0.0149
Note. The results of multilevel linear regression analysis using mixed model to examine associations between program designation (i.e., exception region or application region) and percentages of drug consumption
(antipyretic, analgesic, anti-inflammatory drugs, and psychotropic drugs, adrenal cortical hormones, and antibiotics) in hierarchical data which was consisted of pharmacy and regional levels. Significant level P < 0.05.
If these values were lower than 0.05, it indicated that there were statistically significant associations between independent variable and drug consumption
Model 1 = empty model, Model 2 = only adjusted for pharmacy-level variables, Model 3 = only adjusted regional-level variables, Model 4 = fully adjusted
KRW Republic of Korea Won, ICC Intra-class Correlation Coefficient, the results were rounded to the second digit after the decimal point. df degrees of freedom
aIf p-value were lower than 0.05, it indicated that each level variable had statistically significant association with the outcome variables. The ICC was defined that the ratio of the between cluster variance to the total
variance. It was interpreted as the correlation among observations within the same cluster
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Table 6 Results for multi-level analyses of the associations with percentages of drug consumption in Antibiotics
Variables Antibiotics
Model 1 Model 2 Model 3 Model 4
β SE t df P-Value β SE t df P-Value β SE t df P-Value β SE t df P-Value
Intercept 7.00 0.18 39.29 246 <.0001 6.56 2.83 2.31 246 0.0216 7.72 0.62 12.51 241 <.0001 7.29 2.90 2.52 241 0.0125
Pharmacists and pharmacy
characteristics
Sex of pharmacist
Male 0.08 0.36 0.23 243 0.8207 0.17 0.37 0.45 243 0.6551
Female Ref - - Ref - - Ref - - Ref - -
Age of pharmacist (years)
≤45 3.49 0.51 6.78 722 <.0001 3.42 0.52 6.58 722 <.0001
46–55 2.35 0.52 4.49 722 <.0001 2.24 0.53 4.25 722 <.0001
56–65 1.22 0.55 2.24 722 0.0255 1.12 0.55 2.05 722 0.0404
≥66 Ref - - Ref - - Ref - - Ref - -
Length of operation
≤12 months 2.02 0.57 3.58 454 0.0004 2.02 0.57 3.57 454 0.0004
13–24 months 0.27 0.58 0.47 454 0.6417 0.25 0.58 0.44 454 0.6632
≥25 months Ref - - Ref - - Ref - - Ref - -
Separation of drug prescribing
and dispensing
Exception −1.49 2.35 −0.63 93 0.5283 −1.55 2.35 −0.66 93 0.5134
Application Ref - - Ref - - Ref - - Ref - -
Period of exclusion for
reformed program
≤18 months −0.27 2.81 −0.10 88 0.9240 −0.45 2.81 −0.16 88 0.8720
≥19 months Ref - - Ref - - Ref - - Ref - -
Total drug purchase
(10 million KRW)
−0.02 0.00 −7.93 16,000 <.0001 −0.02 0.00 −7.63 16,000 <.0001
Regional characteristics
Region
Metropolitan −0.03 0.39 −0.07 241 0.9466 −0.02 0.39 −0.04 241 0.9659
Non-metropolitan Ref - - Ref - - Ref - - Ref - -
Yuk
et
al.Substance
A
buse
Treatm
ent,Prevention,and
Policy
 (2015) 10:36 
Page
14
of
19
Table 6 Results for multi-level analyses of the associations with percentages of drug consumption in Antibiotics (Continued)
Total number of clinics in
regions with pharmacies
≤60 −0.31 0.49 −0.62 241 0.5331 −0.30 0.49 −0.61 241 0.5409
≥61 Ref - - Ref - - Ref - - Ref - -
Total number of pharmacy in
regions with pharmacies
≤45 0.85 0.46 1.86 241 0.0646 0.55 0.46 1.21 241 0.2270
≥46 Ref - - Ref - - Ref - - Ref - -
Average of individual income
in regions with pharmacies
≤38 million KRW −0.54 0.41 −1.31 241 0.1917 −0.30 0.41 −0.75 241 0.4568
≥39 million KRW Ref - - Ref - - Ref - - Ref - -
Proportion of national basic
livelihood security beneficiaries
in regions with pharmacies
−0.26 0.14 −1.94 241 0.0537 −0.19 0.14 −1.42 241 0.1584
Random parta Variance SE Z P-Value Variance SE Z P-Value Variance SE Z P-Value Variance SD Z P-Value
Variance of the intercept at
the regional level
0.06 0.40 0.15 0.4411 4.02 33759544.00 0.00 0.5000 0.10 0.39 0.25 0.4014 0.05 0.38 0.14 0.4462
Variance of the intercept at
the pharmacy level
516.25 5.71 90.49 <.0001 511.21 5.64 90.68 <.0001 515.85 5.70 90.50 <.0001 511.09 5.65 90.48 <.0001
ICC 0.0001 0.0078 0.0002 0.0001
Note. The results of multilevel linear regression analysis using mixed model to examine associations between program designation (i.e., exception region or application region) and percentages of drug consumption
(antipyretic, analgesic, anti-inflammatory drugs, and psychotropic drugs, adrenal cortical hormones, and antibiotics) in hierarchical data which was consisted of pharmacy and regional levels. Significant level P < 0.05.
If these values were lower than 0.05, it indicated that there were statistically significant associations between independent variable and drug consumption
Model 1 = empty model, Model 2 = only adjusted for pharmacy-level variables, Model 3 = only adjusted regional-level variables, Model 4 = fully adjusted
KRW Republic of Korea Won, ICC Intra-class Correlation Coefficient, the results were rounded to the second digit after the decimal point, df degrees of freedom
aIf p-value were lower than 0.05, it indicated that each level variable had statistically significant association with the outcome variables. The ICC was defined that the ratio of the between cluster variance to the total
variance. It was interpreted as the correlation among observations within the same cluster
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similar to the results by sex, but the percent of antibi-
otics consumption for the 46–55 year age group was
higher in the application regions (Fig. 2). The results re-
garding the regional characteristics of the pharmacies re-
vealed that in non-metropolitan regions, exception
region pharmacies had higher consumption percentages
of antipyretic, analgesic, anti-inflammatory drugs, in
addition to adrenal cortical hormones, compared with
application region pharmacies. Regarding the operation
time of pharmacies, the values for the antipyretic, anal-
gesic, anti-inflammatory drugs category and the adrenal
cortical hormones category were higher for the excep-
tion region pharmacies, especially for pharmacies that
had been in operation for 13–24 months (Fig. 3).
Discussion
Access and consumption of health care have substantially
increased as socio-economic conditions have improved in
South Korea. This increase has resulted in new problems,
such as increasing medical costs, increased disease cost-
burdens, and increased misuse of drugs. To solve these
problems, the South Korean government introduced a
program that separated drug prescribing from dispensing
[15, 16]. Many articles describing the effects of this pro-
gram have been published by health care professionals
since the program was introduced. Compared with
other OECD countries, drug consumption in South
Korea has continued to increase, but few investigators
have examined drug consumption characteristics in the
program-designated exception regions [6]. We therefore
analyzed the relationships between exception/application
region characteristics and the four categories of drug
consumption to investigate how various factors affect
drug consumption.
The results of our study indicated that compared with
the regions designated as program application regions, ex-
ception regions had higher values for percent consumption
of drugs in the antipyretic, analgesic, anti-inflammatory
drugs category, and in the adrenal cortical hormones
category. It suggested that different prescription pattern in
Fig. 2 Results of the sub-group analysis on the relationships between drug prescribing and dispensing exception and application regions and
drug consumption, by sex and age of the pharmacists. *Statistically significant difference, multilevel linear regression analysis using mixed model.
aThe results of the sub-group analysis by sex of pharmacist, (Male) Antipyretic; Analgesic; Anti-inflammatory drugs = t: 2.76, degrees of freedom
(df): 80, p-value: 0.0071; Psychotropic drugs = t: −1.11, df: 80, p-value: 0.2721; Adrenal cortical hormones = t: 8.60, df: 80, p-value <0.0001;
Antibiotics = t:-0.42, df: 80, p-value: 0.6789. (Female) Antipyretic; Analgesic; Anti-inflammatory drugs = t: 2.36, df: 48, p-value: 0.0224; Psychotropic
drugs = t: 0.18, df: 48, p-value: 0.8608; Adrenal cortical hormones = t: 4.77, df: 48, p-value < 0.0001; Antibiotics = t: −1.37, df: 48, p-value:
0.1756. bThe results of the sub-group analysis by age of pharmacist, (Less than 45 years) Antipyretic; Analgesic; Anti-inflammatory drugs = t: 0.49, df:
21, p-value: 0.6292; Psychotropic drugs = t: 0.41, df: 21, p-value: 0.6878; Adrenal cortical hormones = t: 2.87, df: 21, p-value: 0.0092; Antibiotics = t: −0.46,
df: 21, p-value: 0.6475. (46–55 years) Antipyretic; Analgesic; Anti-inflammatory drugs = t: 2.44, df: 37, p-value: 0.0194; Psychotropic drugs = t: −0.85, df: 37,
p-value: 0.4020; Adrenal cortical hormones = t: 2.78, df: 37, p-value: 0.0085; Antibiotics = t: −2.11, df: 37, p-value: 0.0415. (56–65 years) Antipyretic;
Analgesic; Anti-inflammatory drugs = t: 1.80, df: 48, p-value < 0.001; Psychotropic drugs = t: −0.50, df: 48, p-value: 0.6207; Adrenal cortical
hormones = t: 6.26, df: 48, p-value < .0001; Antibiotics = t: −0.72, df: 48, p-value: 0.4739. (More than 65 years) Antipyretic; Analgesic; Anti-inflammatory
drugs = t: 3.70, df: 63, p-value: 0.0005; Psychotropic drugs = t: −0.51, df: 63, p-value: 0.6134; Adrenal cortical hormones = t: 6.05, df: 63, p-value < 0.0001;
Antibiotics = t: −0.29, df: 63, p-value: 0.7746
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pharmacies by whether designation of program for sepa-
rated drug prescribing from dispensing. We also per-
formed sub-group analyses by pharmacist (i.e., sex, age)
and pharmacy (e.g., region, time since pharmacy began
operation) characteristics. The exception region male
pharmacists had higher values for percent consumption of
antipyretic, analgesic, anti-inflammatory drugs and for ad-
renal cortical hormones, compared with female pharma-
cists. Exception region pharmacies in non-metropolitan
regions also had higher values for percent consumption of
antipyretic, analgesic, anti-inflammatory drugs, compared
with application pharmacies in non-metropolitan regions.
Our findings suggest that the government should con-
sider the characteristics of pharmacies and pharmacists
when managing misuse of drugs because different pre-
scription patterns in pharmacy with region in exception
of program for separated drug prescribing from dispens-
ing could cause misuse behavior in patients. Some alter-
native approaches and regulations arise from our
findings. First, under the existing legislation, pharmacists
in exception regions may dispense drugs (including
“prescription only medicine”) for less than 5 days with-
out a doctor’s prescription. However, in cases outlined
by the Korea Food & Drug Administration, some drugs
for which there are concerns about misuse have been
designated as drugs only prescribed by doctors [17].
Therefore, drugs at a high risk for adverse events should
be placed in a special category by the government. Sec-
ond, it is difficult to monitor drug consumption in ex-
ception regions. Thus, an efficient monitoring system
should be established that includes exception regions
and application regions. These monitoring systems could
help to prevent drug misuse [18–21]. Third, an educa-
tion program that that targets patients at risk for drug
misuse could help to prevent excessive spending. The re-
sults of previous studies indicate that drug use education
programs can effectively assist patients [22, 23]. These
additional activities by the government could be helpful
for reducing unconscious misuse [24]. Finally, based on
our results, there were different patterns of prescriptions
by total drug purchase amount as indirect indicator for
size of each pharmacy. Also, by the categories of drugs,
Fig. 3 Results of the sub-group analysis on the relationships between drug prescribing and dispensing exception regions and drug consumption,
by region and time since pharmacy operation. *Statistically significant difference, multilevel linear regression analysis using mixed model. aThe
results of the sub-group analysis by pharmacy region, (Metropolitan) Antipyretic; Analgesic; Anti-inflammatory drugs = t: 0.11, df: 6, p-value: 0.9173;
Psychotropic drugs = t: −0.44, df: 6, p-value: 0.6755; Adrenal cortical hormones = t: 3.17, df: 6, p-value: 0.0194; Antibiotics = t: −0.08, df: 6, p-value:
0.9388. (Non-metropolitan) Antipyretic; Analgesic; Anti-inflammatory drugs = t: 3.47, df: 86, p-value: 0.0008; Psychotropic drugs = t: −1.11, df: 86,
p-value: 0.2710; Adrenal cortical hormones = t: 8.67, df: 86, p-value < 0.0001; Antibiotics = t: −0.40, df: 86, p-value: 0.6922. bThe results of the sub-group
analysis by time since pharmacy operation, (Less than 12 months) Antipyretic; Analgesic; Anti-inflammatory drugs = t: 1.68, df: 23, p-value:
0.1061; Psychotropic drugs = t: −0.58, df: 23, p-value: 0.5694; Adrenal cortical hormones = t: 6.85, df: 23, p-value < 0.0001; Antibiotics = t: −0.35, df: 23,
p-value: 0.7317. (13–24 months) Antipyretic; Analgesic; Anti-inflammatory drugs = t: 3.08, df: 25, p-value: 0.0050; Psychotropic drugs = t: −0.40, df: 25,
p-value: 0.6932; Adrenal cortical hormones = t: 3.31, df: 25, p-value: 0.0029; Antibiotics = t: −2.49, df: 25, p-value: 0.0196. (More than 25 months)
Antipyretic; Analgesic; Anti-inflammatory drugs = t: −0.56, df: 86, p-value: 0.5798; Psychotropic drugs = t: −0.26, df: 86, p-value: 0.7928; Adrenal cortical
hormones = t: 0.79, df: 86, p-value: 0.4337; Antibiotics = t: −0.40, df: 86, p-value: 0.6922
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there were different patterns of drug consumption.
Thus, it is needed to consider different management
strategies by considering the size of pharmacy and types
of drugs [25].
This study had some strengths compared to previous
investigations. First, to our knowledge, this is first report
on the relationships between the consumption of drugs
at risk for misuse and pharmacy and regional-related
factors in program exception compared with program
application regions. Previous studies of drug consump-
tion only included program application regions. There-
fore, our results will be useful to health policy makers
and professionals for the management of drug consump-
tion. Our study results are also useful for the manage-
ment of drug consumption in South Korea because we
investigated both drugs covered by the National Health
Insurance Services (NHIs) and drugs not covered by the
NHIs. Most of the previous studies examined only data
related to NHIs drugs [15, 26]. Thus, our results are an
indication of the overall status of drug consumption in
South Korea. Our findings can be used by health policy
makers to develop efficient alternative policies.
Our study also had some limitations. First, there might
be different medical needs for different population in
each pharmacy. However, we could not consider drug
consumption details for each prescription or each pa-
tient’s case, because we only included the pharma-
cy—and regional-related factors due to limitations of
data. We also could not analyze the compliance rate of
each patient due to such limitations, even though com-
pliance rate was important factors in analyzing the
pharmaceutical expenditures. Next, we also did not
examine relationships at scale, because our dataset did
not include information on the total drug stock inven-
tory at the beginning of the study period. Third, we only
considered four categories of drugs. This is because
those drugs were reported to cause many side effects by
Korean Food and Drugs Administration. In addition, by
the previous studies, misuse for those drugs could cause
fatal results such as admission in patients with chronic
diseases [27, 28]. Fourth, in South Korea, there are
26,063 pharmacies during 2011 to 2013. However, the
prescription pattern of each pharmacy could affect by
characteristics of each pharmacy such as number of
pharmacists. To analyze with reducing the variation of
prescription pattern, we only included pharmacies with
one pharmacist (N= 16,455; 63.1 % among overall South
Korea) in our dataset. For that reasons, there were some
limitations that it would be difficult to generalize to the
overall South Korean population. Fifth, the length of the
study period was a bit short to reveal the effects of intro-
ducing the program. The beginning of the study period
was >10 years after the date that the program was intro-
duced. Finally, we only used to ratio of purchase about
for four categories drugs as outcomes variables to inves-
tigate the difference patterns of prescription by designa-
tion of program. It was best way if we could use other
types of indicators. However, we could not consider
those due to limitation of data.
Despite these limitations, our results suggested that com-
pared with pharmacies in program application regions,
pharmacies in program exception regions were more likely
to supply antipyretic, analgesic, anti-inflammatory drugs,
and adrenal cortical hormones. Based on these results,
health care professionals and health policy makers should
consider managing health care expenditures by categories
of drugs consumed, especially in exception regions. More
detailed studies of prescribing patterns that use datasets
larger than our dataset are needed to determine effective
strategies.
Conclusions
Compared with program-designated application re-
gions, drug consumption of antipyretic, analgesic,
anti-inflammatory drugs, and of adrenal cortical hormones
was higher in the program regions designated as exception
regions to the rule that separates drug prescribing and dis-
pensing. Characteristics of both pharmacists and pharma-
cies are associated with drug consumption patterns in
program exception regions.
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